Cargando…

Complement Activation in Inflammatory Skin Diseases

The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degra...

Descripción completa

Detalles Bibliográficos
Autores principales: Giang, Jenny, Seelen, Marc A. J., van Doorn, Martijn B. A., Rissmann, Robert, Prens, Errol P., Damman, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911619/
https://www.ncbi.nlm.nih.gov/pubmed/29713318
http://dx.doi.org/10.3389/fimmu.2018.00639
_version_ 1783316243837616128
author Giang, Jenny
Seelen, Marc A. J.
van Doorn, Martijn B. A.
Rissmann, Robert
Prens, Errol P.
Damman, Jeffrey
author_facet Giang, Jenny
Seelen, Marc A. J.
van Doorn, Martijn B. A.
Rissmann, Robert
Prens, Errol P.
Damman, Jeffrey
author_sort Giang, Jenny
collection PubMed
description The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degranulation, which can contribute to the elimination of pathogenic organisms and inflammation. Furthermore, the complement system also has regulating properties in inflammatory and immune responses. Complement activity in diseases is rather complex and may involve both aberrant expression of complement and genetic deficiencies of complement components or regulators. The skin represents an active immune organ with complex interactions between cellular components and various mediators. Complement involvement has been associated with several skin diseases, such as psoriasis, lupus erythematosus, cutaneous vasculitis, urticaria, and bullous dermatoses. Several triggers including auto-antibodies and micro-organisms can activate complement, while on the other hand complement deficiencies can contribute to impaired immune complex clearance, leading to disease. This review provides an overview of the role of complement in inflammatory skin diseases and discusses complement factors as potential new targets for therapeutic intervention.
format Online
Article
Text
id pubmed-5911619
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59116192018-04-30 Complement Activation in Inflammatory Skin Diseases Giang, Jenny Seelen, Marc A. J. van Doorn, Martijn B. A. Rissmann, Robert Prens, Errol P. Damman, Jeffrey Front Immunol Immunology The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degranulation, which can contribute to the elimination of pathogenic organisms and inflammation. Furthermore, the complement system also has regulating properties in inflammatory and immune responses. Complement activity in diseases is rather complex and may involve both aberrant expression of complement and genetic deficiencies of complement components or regulators. The skin represents an active immune organ with complex interactions between cellular components and various mediators. Complement involvement has been associated with several skin diseases, such as psoriasis, lupus erythematosus, cutaneous vasculitis, urticaria, and bullous dermatoses. Several triggers including auto-antibodies and micro-organisms can activate complement, while on the other hand complement deficiencies can contribute to impaired immune complex clearance, leading to disease. This review provides an overview of the role of complement in inflammatory skin diseases and discusses complement factors as potential new targets for therapeutic intervention. Frontiers Media S.A. 2018-04-16 /pmc/articles/PMC5911619/ /pubmed/29713318 http://dx.doi.org/10.3389/fimmu.2018.00639 Text en Copyright © 2018 Giang, Seelen, van Doorn, Rissmann, Prens and Damman. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Giang, Jenny
Seelen, Marc A. J.
van Doorn, Martijn B. A.
Rissmann, Robert
Prens, Errol P.
Damman, Jeffrey
Complement Activation in Inflammatory Skin Diseases
title Complement Activation in Inflammatory Skin Diseases
title_full Complement Activation in Inflammatory Skin Diseases
title_fullStr Complement Activation in Inflammatory Skin Diseases
title_full_unstemmed Complement Activation in Inflammatory Skin Diseases
title_short Complement Activation in Inflammatory Skin Diseases
title_sort complement activation in inflammatory skin diseases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911619/
https://www.ncbi.nlm.nih.gov/pubmed/29713318
http://dx.doi.org/10.3389/fimmu.2018.00639
work_keys_str_mv AT giangjenny complementactivationininflammatoryskindiseases
AT seelenmarcaj complementactivationininflammatoryskindiseases
AT vandoornmartijnba complementactivationininflammatoryskindiseases
AT rissmannrobert complementactivationininflammatoryskindiseases
AT prenserrolp complementactivationininflammatoryskindiseases
AT dammanjeffrey complementactivationininflammatoryskindiseases